More recently the Soto group demonstrated that their α-synuclein-PMCA (utilising the same principle as RT-QuIC; Shahnawaz et al., 2020; Singer et al., 2020) can discriminate between MSA and Lewy Body α-synucleinopathy seeds. This evidence concerns the gene SNCA and multiple system atrophy.